Panax ginseng C.A. Meyer — Asia's most studied medicinal root, used for over 5,000 years, whose ginsenosides modulate dopamine, GABA, nitric oxide synthase, steroid receptors, and ion channels simultaneously, making it one of the most pharmacologically complex plants in clinical phytomedicine.
Panax ginseng is a perennial herb of 30–50 cm growing from a large tuberous root that becomes increasingly ramified with age. The name Panax derives from the Greek pana (all) and axos (cure) — the origin of the word "panacea." The species epithet and common name "ginseng" come from the Chinese jin seng, meaning "man-root" — a reference to the anthropomorphic shape of aged roots, which increasingly resemble the human form. Korean ginseng is the most prized, followed by Chinese and Vietnamese sources.
Ginseng carries the longest documented medicinal history of any plant in the world. Its use is traced back to 3,300 BC in written records, and it is classified as the "best medicine" in the Shen-Nong Pharmacopoeia — one of humanity's earliest medical texts, written around 496 BC. In Chinese medicine, ginseng was used to strengthen the five viscera (heart, liver, lungs, kidneys, spleen), fortify the blood, and increase non-specific resistance to disease — a description that maps precisely onto the modern pharmacological concept of adaptogenicity.
The word "ginseng" derives from the Chinese jin seng — "man-root" — reflecting the plant's most remarkable quality: the anthropomorphic shape of aged roots, which develop a form increasingly reminiscent of the human body. The degree of anthropomorphism increases with the root's age, making old roots (5–7+ years) extraordinarily valuable and the most pharmacologically potent. Panax itself is derived from the Greek words for "all-cure" — the etymological root of "panacea."
Ginseng reached Western awareness through a Jesuit missionary — Father Jartoux — who documented it in France in 1711. American ginseng (Panax quinquefolius) was discovered later by Father Lafitau among the Mohawk people near Montreal, Canada. Once abundant in Quebec's maple forests, wild P. quinquefolius is now considered an endangered species in the USA and Canada, with wild harvesting prohibited.
⚠ Wild American Ginseng — Endangered Species
Panax quinquefolius (American ginseng) is now considered endangered in the USA and Canada — wild harvesting is prohibited. Panax ginseng (Korean/Asian ginseng) is commercially cultivated and not endangered, but only roots grown for 5+ years reach pharmacopoeial quality. Always verify cultivation origin when purchasing.
Ginseng's active fraction contains 30+ individual ginsenosides — each with a distinct pharmacological profile. Understanding the key ginsenosides is essential for evaluating product quality and clinical application.
White Ginseng
Produced from 5–7 year old roots washed, peeled, and sun-dried. Korean pharmacopoeial standard. Retains native ginsenoside profile: primarily Rb1, Rg1, Re, Rc, Rd in natural ratios. Lighter colour, milder taste. Standard for general tonic and adaptogenic applications.
Red Ginseng
Steaming converts Rb1 → Rg3, and Rg1 → Rh1 — producing rarer ginsenosides with stronger anticancer and immunomodulatory profiles. Red-brown horny appearance. Pharmacopoeial in Japan. Most clinical trials for erectile dysfunction and cognitive enhancement use KRG (Korean Red Ginseng).
Rg1 is a protopanaxatriol-type ginsenoside with the strongest documented cognitive and neuroprotective activity. It improves memory and learning via acetylcholinesterase inhibition and hippocampal action. Rg1 is cardioprotective, nephroprotective, and retinoprotective in hypertensive rat models.[31] It stimulates NO synthase in cerebral, peripheral vascular, cardiac, and urogenital tissue — providing both vasodilating and cognitive effects from a single mechanism.[28] Rg1 also has mild stimulant activity, activating spontaneous motor activity in aged rats.[20]
Rb1 is a protopanaxadiol-type ginsenoside representing one of the highest-concentration ginsenosides in white ginseng root. It provides core adaptogenic, anti-inflammatory, and modulatory effects. During red ginseng processing (steaming), Rb1 is converted to Rg3 — expanding its pharmacological range. Rb1 activates intracellular steroid receptors (including oestrogen receptor subtypes),[27] explaining ginseng's oestrogenic activity and relevance to menopause symptoms. Its anabolic properties derive from structural similarity to steroidal hormones.
Rg3 is formed during red ginseng processing from the precursor Rb1 and is the principal anticancer ginsenoside. Its documented mechanisms include: anti-angiogenesis (inhibition of new blood vessel formation that tumours require for growth), inhibition of cancer cell invasion, and inhibition of metastasis. It also inhibits tumour NF-κB activation, reducing cancer cell survival signalling.[42] Rg3 is not present in white ginseng and represents one of the primary pharmacological reasons to specify red ginseng for cancer-related supportive applications.
Rb3 protects cardiomyocytes against ischaemia–reperfusion injury via inhibition of the JNK-mediated NF-κB pathway — reducing cardiomyocyte apoptosis during myocardial ischaemic events.[32] This mechanism positions Rb3 as the primary ginsenoside of interest for cardiovascular protective applications, complementing Rg1's NO synthase-mediated vasodilation. Ginsenoside Ro separately inhibits platelet aggregation and thromboxane formation, providing antiplatelet activity with clinical relevance for warfarin interaction risk.[29]
⚠ Product Quality — What "Standardised to 7% Ginsenosides" Actually Means
Total ginsenoside content is not the same as ginsenoside ratio — and ratio determines clinical effect.
Two products both "standardised to 7% ginsenosides" can have completely different pharmacological profiles depending on which ginsenosides make up that 7%. A product rich in Rg1 and Rb1 has cognitive and adaptogenic strength. A red ginseng product containing Rg3 and Rh2 has anticancer and immunomodulatory advantage. Always ask the supplier for a full ginsenoside HPLC panel, not just total ginsenoside content. See ref [29] for the full pharmacological table of each ginsenoside's contribution to the TNF-alpha anti-inflammatory pathway alone.
Only the root is used medicinally. Root age critically determines ginsenoside content — 5-year minimum, 6–7 years optimal. Older roots are more anthropomorphic and pharmacologically superior.
The subterranean root of P. ginseng, harvested after minimum 5 years of cultivation. Younger roots contain insufficient ginsenoside concentrations. The French Pharmacopoeia (List A) recognises the subterranean part. Panax pseudoginseng var. notoginseng root is also pharmacopoeial in France.
Ginsenosides · Polysaccharides · Vitamins B
P. quinquefolius (American ginseng) has more hypoglycaemic activity than Asian ginseng[37][38] but is endangered in the wild. Aralia mandshurica (Manchurian ginseng, Araliaceae) has immunostimulant phagocytosis activity persisting 70 days post-administration — a distinct species, not a substitute. Always verify the species, origin, and root age in the product's certificate of analysis.
From the WHO monograph and primary literature. Extracts standardised to 7% ginsenosides are the clinical reference. Minimum 4 weeks of continuous use is required for adaptogenic effects to manifest.
The root contains 30+ ginsenosides, polysaccharides, B-vitamins, essential amino acids, sterols, and essential oil. The ginsenoside fraction (1.5–8% dry weight) is the primary active and standardisation marker.
Ginseng's defining property — improves physical and mental performance and increases non-specific resistance to stress through multiple parallel mechanisms. A systematic review of randomised clinical trials (Vogler et al., 1999) confirmed adaptogenic efficacy.[3] Commission E and WHO both recognise this as the primary indication. Adaptogenic activity involves modulation of the HPA axis, catecholamine inhibition in adrenal chromaffin cells,[33][34] and dopaminergic system upregulation.[15]
Ginseng increases phagocytosis, stimulates T and B lymphocyte production,[9] induces dendritic cell maturation and Th-1 immune response,[10] and increases NK (natural killer) cell activity.[12] Most clinically relevant: standardised extract G115 potentiates influenza vaccination by increasing NK cell activity — a double-blind RCT (Scaglione et al., 1996) demonstrated significant reduction in influenza incidence in vaccinated adults supplementing with ginseng.[13]
Improves memory formation, recall, attention, and processing speed. Mechanisms include: acetylcholinesterase inhibition, hippocampal modulation, and Rg3-enriched extract amelioration of scopolamine-induced learning deficits in animal models.[22] Multiple RCTs confirm cognitive enhancement. An open-label trial found Korean Red Ginseng beneficial as adjuvant treatment for cognitive impairment in Alzheimer's disease patients.[25]
Ginseng and individual ginsenosides (especially Rg1 and Re) protect neurons against multiple insults — oxidative stress, excitotoxicity, and neuroinflammation. A comprehensive review (Ong et al., 2015) confirmed neuroprotective effects across neurological disorder models.[23] Dopaminergic neuroprotection is documented in two rodent Parkinson's disease models (Van Kampen et al., 2014),[17] positioning ginseng as a candidate adjunct in neurodegenerative disease management.
Stimulates insulin secretion and increases peripheral glucose consumption via glycan polysaccharides.[35] Fermented red ginseng reduces postprandial hyperglycaemia in type 2 diabetes in a double-blind RCT.[36] American ginseng (P. quinquefolius) is more potently hypoglycaemic than Asian ginseng.[38] Lowers cholesterol and improves glucose tolerance. The antidiabetic effect is slow to manifest — most relevant for reducing antidiabetic drug doses in elderly patients under medical supervision.
Anti-inflammatory activity via TNF-alpha inhibition — ginsenoside effects on this pathway are extensively mapped in a comprehensive review (Lee & Lau, 2011).[29] Ginseng polysaccharides have potential in autoimmune diseases by dually modulating TNF-alpha (raising it in healthy tissue while lowering it in inflamed intestinal mucosa).[30] Ginsenoside Ro inhibits capillary permeability and platelet aggregation/thromboxane formation.
Ginsenoside Rg1 provides cardiovascular protection in hypertensive animal models — protecting cardiac, renal, and retinal tissue from hypertensive damage.[31] Ginsenoside Rb3 protects cardiomyocytes against ischaemia–reperfusion injury via JNK/NF-κB pathway inhibition.[32] In athletes, ginseng increases oxygen absorption capacity, reduces blood lactate, lowers heart rate, and reduces adrenaline hypersecretion from the adrenal medulla.
One of ginseng's most rigorously validated traditional uses. Korean Red Ginseng is superior to placebo for erectile dysfunction in a systematic review of RCTs (Jang et al., 2008).[43][44] Mechanism: ginsenosides stimulate NO synthase in corpus cavernosum smooth muscle, increasing nitric oxide production — the same physiological mechanism exploited by PDE5 inhibitors.[28]
Ginsenosides activate intracellular steroid receptors including oestrogen receptor subtypes.[27] Korean Red Ginseng improves menopause symptoms, depressive symptoms, and sexual dysfunction of menopausal origin.[7] Significantly improves cortisol/DHEA ratio in patients with severe climacteric syndromes (Tode et al., 1999).[6] Contraindicated in oestrogen-sensitive cancers due to oestrogenic activity.
Protection depends on which ginsenosides are present: Rh-1 and Rh-2 inhibit human ovarian cancer cell growth in mice; Rg-3 is anti-angiogenic and inhibits cancer cell invasion and metastasis; Rb-2 inhibits angiogenesis.[42] These are mechanistic preclinical findings — not clinical cancer treatment claims. Red ginseng (richer in Rg3) has stronger mechanistic rationale for cancer-supportive applications than white ginseng.
Hydroponically grown red ginseng reduces perceived stress level and regulates emotional processing in moderately stressed adults — a 2025 randomised, double-blind, placebo-controlled study (Dormal et al., Nutrients).[39] Additionally improves alcohol clearance in humans — subjects supplementing ginseng have measurably lower blood alcohol concentrations after consuming equivalent alcohol compared to controls.[41]
WHO and Commission E recognised indications plus evidence-supported applications from systematic reviews and RCTs.
Ginseng is pharmacologically unique in its multi-system reach — simultaneously modulating dopaminergic, GABAergic, NO synthase, ion channel, and steroid receptor pathways through individual ginsenosides with distinct targets.
Ginseng saponins modulate the dopaminergic system — increasing blood dopamine levels and producing dopaminergic effects.[15][16] Specifically, ginseng total saponins modulate dopamine release and tyrosine hydroxylase gene expression in the rat. This dopaminergic upregulation underlies ginseng's cognitive enhancement, mood improvement, and its potential relevance in Parkinson's disease — where dopaminergic neuroprotection has been demonstrated in two rodent models.[17][18] The interaction with nicotine-induced dopaminergic transmission is also documented, suggesting ginseng may modulate nicotine reward pathways.[15]
Ginsenosides have important activity on the central nervous system through regulation of multiple ion channel types — inhibiting voltage-dependent Ca2+, K+, and Na+ channels, inhibiting N-methyl-D-aspartate (NMDA) channels, nicotinic acetylcholine receptors, and 5-HT3 (serotonin type 3) receptors.[21] This multi-channel modulation — particularly NMDA inhibition (preventing excitotoxic neuronal death) and ion channel regulation — underlies ginseng's neuroprotective activity, cognitive enhancement, and potential in Alzheimer's and Parkinson's disease. No other single class of phytochemical has this breadth of ion channel activity.
Ginseng stimulates NO synthase (NOS) activity in cerebral, peripheral vascular, cardiac, and urogenital tissue.[28] This NOS stimulation produces tissue-specific effects: in the brain — vasodilation and cognitive support; in the heart — cardioprotective vasodilation; in corpus cavernosum smooth muscle — erection physiology (explaining the aphrodisiac reputation and its validation by ED RCTs). Gillis (1997) proposed that NOS stimulation is the "nitric oxide link" explaining ginseng's diverse cardiovascular effects. This mechanism is distinct from PDE5 inhibitors (which prevent NO degradation) — ginseng increases NO production rather than preventing its breakdown.
Ginseng saponins inhibit catecholamine (adrenaline, noradrenaline) secretion from bovine adrenal chromaffin cells — the cells responsible for the "fight-or-flight" stress hormone response.[33][34] By reducing acetylcholine-evoked Na+ influx and catecholamine secretion, ginseng attenuates the acute stress response, reducing adrenaline hypersecretion during exercise (explaining improved lactate and heart rate parameters in athletes) and buffering the cortisol response to psychological stress. This HPA axis modulation — combined with dopaminergic upregulation — is the core molecular explanation for ginseng's adaptogenic activity.
Four distinct species and two processing methods — each with different ginsenoside profiles and clinical applications. Sourced from Chen et al. 2008 (Acta Pharmacol Sin).[1]
Same species (P. ginseng), different processing — producing a different ginsenoside profile. Sourced from Chen et al. 2008.[1]
Which Type Should You Choose?
For fatigue, general vitality, and athletic performance: white or red P. ginseng — both effective. For erectile dysfunction or cognitive enhancement: Korean Red Ginseng (KRG) — most RCTs use this form. For type 2 diabetes glucose management: P. quinquefolius (American ginseng) — more potently hypoglycaemic. For trauma, bleeding, or post-surgical recovery: P. notoginseng (Tienchi ginseng) — completely different clinical role. Avoid substituting species — they are not interchangeable despite sharing the "ginseng" name.
The two most searched adaptogens in the world — with complementary rather than competing pharmacology. Understanding the difference prevents therapeutic misallocation.
Clinical Bottom Line
Choose ginseng when the priority is energy, cognition, erectile function, immune potentiation, or athletic performance. Choose ashwagandha when the priority is anxiety reduction, cortisol management, testosterone support, or sleep quality. The two adaptogens can safely be combined — their mechanisms operate through distinct and complementary pathways, with no documented pharmacokinetic interaction.
Generally well tolerated at standard doses. High-dose adverse effects and drug interactions are clinically significant. Absolute contraindication in pregnancy.